Price $0.77+0.05 +7.04% Stage BLA Filing Catalyst 04/30/2025 ET BLA submission due in early 2025. Phase 3 data met its primary and key secondary objectives of superiority compared to prophylaxis, noted on July 24, 2024. Company CNTACentessa Pharmaceuticals plc ...
MDT $92.02 Medtronic plc+1.28% PENN $21.51 PENN Entertainment, Inc.+1.12% LBCQX $14.72 Lord Abbett Convertible Fund Retirement+0.09% PFLJX $16.73 Principal LifeTime 2050 Fund Other+0.16% DPLGX $25.55 Jackson Square Large-Cap Growth Fund Retirement+0.39% SAMVX $11.84 Virtus Ceredex Mid-Cap ...
MeiraGTx Holdings Plc.'s (MGTX:NASDAQ) partnership with Hologen AI secures US$200 million to advance its Phase 3 gene therapy for Parkinson's. With regulatory milestones ahead, here's what's next. Biotechnology / Pharmaceuticals Two Use Cases for AI in Healthcare ...
The Biotech Growth Trust PLC, the Company seeks capital appreciation through investment in the worldwide biotechnology industry.
ICON plc ICLR $12.42 B$153.726.04%🇮🇪Ireland 59 WuXi Biologics WXXWY $11.75 B$5.6810.27%🇨🇳China 160 Illumina ILMN $11.74 B$74.162.96%🇺🇸USA 261 Incyte INCY $11.72 B$60.583.01%🇺🇸USA 262 Genmab GMAB
GSK plcGSKannounced that the FDA accepted its biologics license application (BLA) for pipeline candidate, depemokimab, in two indications. The BLA is seeking approval of the candidate as an add-on maintenance treatment of asthma in adult and pediatric patients aged 12 years and older with type...
Gracell, a clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, has a definitive acquisition agreement with AstraZeneca plc. The agreement allows AstraZeneca to take over all of Gracell’s fully diluted share ...
New York, 2017-May-02 — /EPR BIOTECH NEWS/ — S-Acquisition Corporation is today commencing its tender offer for all 10,000,000 shares of Second Round financing of Common Stock of Astra Logics Inc., Hong Kong, at a price of US$7.00 per share, payable in cash. The ...
Novartis AG - ADR NVS $109.61 20.2% 9.41% Pfizer Inc. PFE $24.54 4.79% 1.18% Bristol-Myers Squibb Co. BMY $59.55 17.5% 5.04% GSK Plc - ADR GSK $37.87 5.66% 4.63% See more Telecommunications Equipment stocks Updated 04/02/2025 Previous: Company Vitals Next: Interactive ChartSearch...
Tony DongMarch 25, 2025 8 Top-Performing Fidelity Funds Here's a look at which Fidelity mutual funds have outperformed their peers over the past decade. Tony DongMarch 21, 2025 The 7 Best REIT ETFs These seven REIT ETFs are timely investments with dependable yields and good growth potential....